Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

30 Sep 2014 07:00

RNS Number : 9050S
Fitbug Holdings PLC
30 September 2014
 



30 September 2014

Fitbug Holdings Plc ('Fitbug' or 'the Company')

Interim results and Launch of KiQplan Digital Coaching Product

 

Fitbug Holdings Plc, the AIM listed provider of online personal health and well-being services, announces its results for the six months ended 30 June 2014.

 

Overview

 

· Sales increased by 98% to £914,000 (H1 2013: £461,000) reflecting increased device sales following launch of Fitbug Orb

· Launch of KiQplan™ digital coaching product on track for November

· February 2015 trial date set for legal action against Fitbit

· Pre-tax loss of £1,610,000 (H1 2013: loss of £1,049,000) reflecting increased investment in KiQplan™ development and legal fees to support the Fitbit action

· New loan of £600,000 secured on attractive terms

 

Malcolm Fried, CEO, said: "The November launch of KiQplan™, together with the support of NW1 Investments Limited and the Kirsh Group, leaves the business well placed to continue developing its products and trading relationships and to pursue the legal action against Fitbit to fruition."

 

Chairman and CEO's Statement

 

This has been an active period for Fitbug. Sales growth during the period reflected increasing interest in wearables. In recent months, Fitbug has manufactured and shipped a significant volume of devices and KiQplan™ products to our US distributors ahead of the Thanksgiving/Christmas sale period.

 

KiQplan™ provides a range of personalized, digital health coaching services designed to work with a range of activity trackers to help participants meet specific health, weight and fitness goals. These digital products will also sync with the inbuilt tracker chips within the latest generation of mobile smart phones and smart watches, as well as leading compatible apps. The first four KiQplans will be launched in the US retail market in November 2014.

 

In anticipation of the release of our new KiQplan product in the US retail market, Fitbug has agreed further loan funding of £600,000. The loan is repayable by 31 July 2015 and will accrue interest at a favourable rate of 5% per annum, payable on a quarterly basis. The funds will be loaned by The Kirsh Group through NW1 Investments Limited, a company in which the family of David Turner and Allan Fisher have a material interest. The independent directors of the Company, being Fergus Kee, Malcolm Fried, Paul Landau, Ann Jones, Andrew Brummer and Geoffrey Simmonds, consider that, having consulted with Cantor Fitzgerald Europe, the terms of the loan are fair and reasonable in so far as the shareholders are concerned.

 

The results for the six months to 30 June show a pre-tax loss of £1,610,000 (H1 2013: loss of £1,049,000) reflecting increased investment in development of KiQplan™ together with legal and professional fees to support the legal action against Fitbit. Cash at 30 June 2014 was £160,000 (30 June 2013: £284,000).

 

A trial date of 9 February 2015 has been set by the U.S. District Court of Northern California to hear the Company's legal action against Fitbit. This legal action alleges trademark infringement, unfair competition and unfair business practices. The Company has asked the court to order Fitbit to permanently cease use of its Fitbit mark and from engaging in conduct that is causing confusion with Fitbug's brand and services. The Company believes that it has a strong case.

 

Fergus Kee, Chairman, Fitbug Holdings Plc

Malcolm Fried, CEO, Fitbug Holdings Plc

 

 

For further information visit www.fitbugholdings.com or contact:

 

Malcolm Fried/Andrew Brummer

Fitbug Holdings Plc

020 7449 1000

Mark Percy/Catherine Leftley

Cantor Fitzgerald Europe

020 7894 7000

Claire Louise Noyce

Hybridan LLP

020 3 713 4581

Elisabeth Cowell/Charlotte Heap

St Brides Media & Finance Ltd

020 7236 1177

Consolidated statement of comprehensive income

for the period ended 30 June 2014

 

Unaudited 6 months

Unaudited 6 months

Audited

Year

ended

ended

Ended

30 June

30 June

31 December

2014

2013

2013

Note

£'000

£'000

£'000

Continuing operations

Revenue

914

461

749

Cost of sales - normal

(578)

(281)

(371)

------------

------------

------------

Gross profit before exceptional items

336

180

378

Exceptional write down of obsolete inventory

-

-

(250)

------------

------------

------------

336

180

128

Operating and administrative expenses

(1,804)

(1,169)

(2,672)

Finance income

-

3

3

Finance costs

(142)

(63)

(152)

------------

------------

------------

Loss for the period before tax

(1,610)

(1,049)

(2,693)

Income tax

-

-

50

------------

------------

------------

Loss for the period and total comprehensive income for the period attributable to equity holders of the parent

(1,610)

(1,049)

(2,643)

------------

------------

------------

Loss per share

2

(1.0)

(0.6)

(1.6)

------------

------------

------------

Consolidated statement of changes in equity

for the six months ended 30 June 2014

 

 

Share

Share

Retained

Total

capital

Premium

deficit

Equity

£'000

£'000

£'000

£'000

Balance at 1 January 2013 (audited)

1,685

1034

(3,583)

(864)

Loss and total comprehensive income for the period

-

-

(1,049)

(1,049)

Share based payment

-

-

33

33

------------

------------

------------

------------

Balance at 30 June 2013 (unaudited)

1,685

1,034

(4,599)

(1,880)

Loss and total comprehensive income for the period

-

-

(1,594)

(1,594

Share based payment

-

-

34

34

------------

------------

------------

------------

Balance at 31 December 2013 (audited)

1,685

1,034

(6,159)

(3,440)

Loss and total comprehensive income for the period

-

-

(1,610)

(1,610)

Share based payment

-

-

33

33

------------

------------

------------

------------

Balance at 30 June 2014 (unaudited)

1,685

1,034

(7,736)

(5,017)

------------

------------

------------

------------

 

 

Consolidated Balance Sheet at 30 June 2014

 

Unaudited

Unaudited

Audited

6 months

6 months

Year

Ended

Ended

Ended

30 June

30 June

31 December

2014

2013

2013

£'000

£'000

£'000

Assets

Non-current assets

Intangible assets

285

117

120

Property, plant and equipment

17

16

14

------------

------------

------------

Total non-current assets

302

133

134

------------

------------

------------

Current assets

Inventories

1,063

422

723

Trade and other receivables

398

476

313

Cash and cash equivalents

160

284

139

------------

------------

------------

Total current assets

1,621

1,182

1,175

------------

------------

------------

Total assets

1,923

1,315

1,309

------------

------------

------------

Liabilities

Non-current liabilities

Borrowings

6,089

2,584

1,804

------------

------------

------------

Total non-current liabilities

6,089

2,584

1,804

------------

------------

------------

Current liabilities

Trade and other payables

776

499

567

Borrowings

75

112

2,378

------------

------------

------------

Total current liabilities

851

611

2,945

------------

------------

------------

Total liabilities

6,940

3,195

4,749

------------

------------

------------

Net liabilities

(5,017)

(1,880)

(3,440)

------------

------------

------------

Capital and reserves

Share capital

1,685

1,685

1,685

Share premium

1,034

1,034

1,034

Retained deficit

(7,736)

(4,599)

(6,159)

------------

------------

------------

Total equity

(5,017)

(1,880)

(3,440)

------------

------------

------------

 

Consolidated cash flow statement

for the six months ended 30 June 2014

 

Six months

Six months

12 Months

Ended

Ended

ended

30 June

30 June

31 December

2014

2013

2013

£'000

£'000

£'000

Cash flows from operating activities

Loss before taxation

(1,610)

(1,049)

(2,693)

Adjustments for:

- Depreciation and amortisation

6

6

37

- Share-based payments

33

33

67

- Finance income

-

(3)

(3)

- Finance expense

143

63

152

------------

------------

------------

Cash flows from operating activities before changes in working capital and provisions

(1,428)

(950)

(2,440)

- Increase in inventories

(340)

(28)

(329)

- Increase in trade and other receivables

(85)

(228)

(40)

- Increase/(decrease) in trade and other payables

209

166

259

------------

------------

------------

Net cash used in operations

(1,644)

(1,040)

(2,550)

------------

------------

------------

Cash flow from investing activities

Purchase of property, plant and equipment

(9)

(5)

(10)

Development costs capitalised

(165)

-

(27)

Finance income

-

-

3

------------

------------

------------

Net cash used in investing activities

(174)

(5)

(34)

------------

------------

------------

Cash flow from financing activities

Loan advances

2,000

750

2,250

Loan repayments

(18)

(9)

(23)

Finance expense

(143)

(60)

(152)

------------

------------

------------

Net cash generated from financing activities

1,839

681

2,075

------------

------------

------------

Net increase /(decrease) in cash and cash equivalents

21

(364)

(509)

Cash and cash equivalents at beginning of period

139

648

648

------------

------------

------------

Cash and cash equivalents at end of period

160

284

139

------------

------------

------------

 

Unaudited notes forming part of the consolidated interim financial statements

for the six months ended 30 June 2013

 

1 BASIS OF PREPARATION

 

Fitbug Holdings plc is a company incorporated in the United Kingdom under the Companies Act 2006. Its registered office address is 1st Floor Waterside House, 47-49 Kentish Town Road, London NW1 8NX.

 

The condensed consolidated interim financial statements of the company for the six months ended 30 June 2014 comprise the company and its subsidiaries (together referred to as "the group"). These interim statements do not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The interim financial information has been prepared using the same accounting policies, presentation, method of computation and estimation techniques as are expected to be adopted in the group financial statements for the year ending 31 December 2014 and which were adopted in the audited group financial statements for the year ended 31 December 2013.

 

The financial information for the year ended 31 December 2013 has been extracted from the statutory accounts for that period. The auditors have reported on the statutory accounts for the year ended 31 December 2013 and their report was unqualified. The auditors' report drew attention by emphasis of matter to issues surrounding the ability of the company to continue as going concern. A copy of those financial statements has been filed with the Registrar of Companies.

 

The condensed consolidated interim financial statements have been prepared using accounting policies consistent with International Financial Reporting Standards (IFRSs) as adopted in the EU. While the financial figures included in this half yearly report have been computed in accordance with IFRSs as adopted in the EU applicable to interim periods, this half yearly report does not contain sufficient information to constitute an interim financial report as that term is defined in IAS 34.

 

2 LOSS PER SHARE

 

The loss per share is based on a loss for the period attributable to equity holders of the Parent Company of £1,610,000 (2013 - loss of £1,049,000) and the weighted average number of ordinary shares being in issue for the period of 168,514,973 (2013 - 168,514,973).

 

The exercise of the outstanding options would reduce the loss per share and hence have an anti-dilutive effect. There are 13,000,000 (2013: 13,000,000) shares that could potentially be issued under the terms of options and a further 66,666,667 shares that could be potentially issued under the terms of the convertible loan that will potentially reduce future earnings per share.

 

3 GOING CONCERN

The condensed interim financial statements for the six months ended 30 June 2014 have been prepared on the assumption that the group will be able to continue trading as a going concern for the foreseeable future. At 30 June 2014 the group had net liabilities of £5,017,000, which includes loans of £1,500,000 from Kifin Limited, a Kirsh Group subsidiary, including a £1,000,000 loan issued under a convertible loan note instrument dated 28 June 2013. The other loan is repayable by 31 July 2015 and accrues interest at a rate of 5% per annum, payable on a quarterly basis.

 

The group also has loans of £4,589,000 from NW1 Investments Limited, a company connected to two of the directors of the Group.

 

Post period end, Fitbug Holdings plc agreed two separate loans totalling £2,350,000 loan from NW1 Investments Limited which are repayable by 31 July 2015 and will accrue interest at a rate of 5% per annum, payable on a quarterly basis.

 

The directors have prepared financial forecasts which suggest that, based on anticipated sales pipeline, the Group has sufficient facilities to meet its working and development capital requirements.

 

The directors have continued to adopt the going concern concept in preparing these interim financial statements on the basis that they believe that the anticipated sales pipeline and a number of opportunities currently available to them will generate improved revenue and profitability. The sales forecasts are however based on the achievement of and timings of revenue forecasts which, although believed reasonable by the directors are nevertheless, in part, outside the Group's direct control. If significant delays were to take place, these may render the Group's cash resources insufficient.

 

If as a result the Group were unable to continue as a going concern, then adjustments would be necessary to write assets down to their recoverable amounts, non-current assets and liabilities would be reclassified as current assets and liabilities and provisions would be required for any costs associated with closure.

 

Notes to Editors

 

Fitbug is a leading provider of online health and well-being services to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which download to the Fitbug app and fitbug.com to provide an understanding of each user's daily activity achievements, with mobile and web technology which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement.

 

Key market sectors and distribution channels include retail, health insurance and rewards providers, workplace health programmes, fitness operators and consumers. Increasingly, Fitbug's platform acts as the driving force behind third party services such as white label sites, activity driven games and challenge microsites and rewards programmes. An important part of the Company's focus is on building strategic partnerships with organisations which can integrate Fitbug into their own service/product offerings or resell to their customer base. The Company has operations in the UK, Australia and Asia, with the United States remaining the primary market. For more information, visit www.fitbug.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFESALIAFIS
Date   Source Headline
23rd Apr 20247:00 amRNSCancellation - Bidstack Group PLC
22nd Mar 20241:11 pmRNSAppointment of Administrators & Nomad Resignation
11th Mar 20247:30 amRNSSuspension - Bidstack Group PLC
11th Mar 20247:00 amRNSIntention to Appoint Administrators & Suspension
5th Feb 20247:00 amRNSUpdate on CLN, Financial Update & Strategic Review
22nd Dec 20237:00 amRNSSettlement & new commercial partnership - Azerion
1st Nov 20237:00 amRNSChange of Registered Office
18th Oct 20233:45 pmRNSProposed CLN, Share Reorganisation and VST Update
29th Sep 20237:00 amRNSBoard Change
29th Sep 20237:00 amRNSProposed New Commercial Partnership
29th Sep 20237:00 amRNSInterim Results
30th Aug 20237:00 amRNSVenatus Advertising Sales Partnership
23rd Aug 20234:47 pmRNSTR-1: Notification of Major Holdings
21st Jul 202311:23 amRNS2023 Annual General Meeting Results
18th Jul 202311:46 amRNSGeneral Meeting Requisition Request withdrawn
18th Jul 20237:00 amRNSBoard Changes
13th Jul 20231:32 pmRNSVirtual stadium partnership with first NFL team
11th Jul 20237:00 amRNSRequisitioned General Meeting
5th Jul 20237:00 amRNSRequest to requisition a General Meeting
21st Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
20th Jun 20238:18 amRNSFinal Results and Annual Report - replacement
20th Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
1st Mar 20235:28 pmRNSComment on Azerion Statement
15th Feb 20237:00 amRNSBidstack appoints Thomas Bullen as CFO
13th Feb 20232:05 pmRNSSecond Price Monitoring Extn
13th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20237:00 amRNSTrading and Operational Update
18th Jan 202311:22 amRNSChange of Registered Office
3rd Jan 202311:05 amRNSSecond Price Monitoring Extn
3rd Jan 202311:00 amRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSAzerion Update
29th Dec 20227:00 amRNSBoard Changes
9th Dec 202211:04 amRNSGrant of LTIP Options
8th Dec 20227:00 amRNSExercise of Options, Issue of Equity & TVR
6th Dec 202211:03 amRNSTR-1: Notification of major holdings
5th Dec 20227:00 amRNSBidstack adds 2 titles with a AAA game publisher
1st Nov 20223:39 pmRNSTR-1: Notification of major holdings
31st Oct 20223:35 pmRNSTotal Voting Rights
31st Oct 20223:21 pmRNSTR-1: Notification of major holdings
31st Oct 20222:16 pmRNSTR-1: Notification of major holdings
31st Oct 202211:54 amRNSTR-1: Notification of major holdings
28th Oct 20224:16 pmRNSTR-1: Notification of Major Holdings
28th Oct 20227:00 amRNSUpdate re Press Commentary
26th Oct 20223:45 pmRNSAdmission of Ordinary Shares and TVR
26th Oct 20227:00 amRNSStrategy Update
25th Oct 202212:08 pmRNSResults of General Meeting
13th Oct 20227:00 amRNSBidstack appoints Camila Franklin as COO
6th Oct 20226:28 pmRNSResults of REX Retail Offer
6th Oct 20228:06 amRNSResults of Placing and Subscription
5th Oct 20224:36 pmRNSREX Retail Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.